期刊文献+
共找到5篇文章
< 1 >
每页显示 20 50 100
支气管舒张试验对慢性阻塞性肺疾病患者脉冲振荡参数的影响 被引量:7
1
作者 魏兵 聂秀红 +3 位作者 周玉涛 陈玉 高赏 任魁 《临床肺科杂志》 2018年第2期263-265,269,共4页
目的探讨支气管舒张试验对不同程度慢性阻塞性肺疾病患者脉冲振荡参数的影响。方法选取2012年11月至2014年5月于首都医科大学宣武医院就诊的慢性阻塞性肺疾病稳定期患者163例,其中男性85例,女性78例,按2011版GOLD策略将患者分为A、B、C... 目的探讨支气管舒张试验对不同程度慢性阻塞性肺疾病患者脉冲振荡参数的影响。方法选取2012年11月至2014年5月于首都医科大学宣武医院就诊的慢性阻塞性肺疾病稳定期患者163例,其中男性85例,女性78例,按2011版GOLD策略将患者分为A、B、C、D组,所有患者均行支气管舒张试验。在支气管舒张试验前、后行脉冲振荡法检查,主要测量呼吸总阻抗(Zrs)、总气道阻力(R5)、周围气道阻力(R5-R20)、共振频率(Fres)、周边弹性阻力(X5)、中心阻力(RC)、周边阻力(RP)。结果 A组患者,Fres、Zrs、R5、R5-R20指标在支气管舒张试验前后相比,均有所下降(P均<0.05),而支气管舒张试验后Rc、Rp等较试验前相比,均有所下降(P均<0.05),而X5试验前后比较,则无统计学意义(P均>0.05)。B组患者支气管舒张试验后各项指标均有所改善(P均<0.05)。C组患者支气管舒张试验前后RP、RC无统计学差异(P均>0.05)。D组患者支气管舒张试验前后R5-R20、Rc无统计学差异(P均>0.05),Rp有所下降,P均<0.05。结论脉冲振荡检查技术可以监测肺功能的变化,指导临床用药。 展开更多
关键词 慢性阻塞性肺疾病 脉冲振荡法 支气管舒张试验
下载PDF
不同剂量地高辛在呼吸机机械通气肺心病患者的不良反应观察 被引量:1
2
作者 滕国杰 聂秀红 杨强 《临床肺科杂志》 2018年第7期1250-1252,共3页
目的观察呼吸机机械通气的慢性肺源性心脏病患者使用不同剂量地高辛治疗的不良反应发生情况。方法回顾性分析80例呼吸机机械通气的慢性肺源性心脏病患者,按地高辛使用情况分成三组,36例接受0.125 mg地高辛治疗,12例接受0.25mg地高辛治疗... 目的观察呼吸机机械通气的慢性肺源性心脏病患者使用不同剂量地高辛治疗的不良反应发生情况。方法回顾性分析80例呼吸机机械通气的慢性肺源性心脏病患者,按地高辛使用情况分成三组,36例接受0.125 mg地高辛治疗,12例接受0.25mg地高辛治疗,32例非地高辛治疗患者作为对照。三组患者治疗7天后,测定地高辛浓度,患者BNP、UCG的情况,观察地高辛不良反应状况。结果治疗7天后,0.125 mg地高辛组患者与非地高辛组患者相比BNP改善明显,且不良反应发生率低。0.25mg地高辛治疗组患者由于出现明显的心律失常,给予地高辛减量或停用,均未用至7天。结论 0.125 mg地高辛治疗呼吸机机械通气的慢性肺心病患者相对安全,可以改善患者的心功能。 展开更多
关键词 地高辛 不良反应 呼吸机机械通气 慢性肺源性心脏病
下载PDF
The cross-sectional and longitudinal association of the BODE index with quality of life in patients with chronic obstructive pulmonary disease 被引量:9
3
作者 LIN Ying-xiang XU Wan-ning +12 位作者 LIANG Li-rong PANG Bao-sen nie xiu-hong ZHANG Jie WANG Hong LIU Yu-xiang WANG Dan-qi XU Zhen-yang WANG Hong-wu ZHANG Hu-sheng HE Zheng-yi YANG Ting WANG Chen 《Chinese Medical Journal》 SCIE CAS CSCD 2009年第24期2939-2944,共6页
Background The body mass index, airflow obstruction, dyspnea, and exercise capacity (BODE) index was shown at predicting the risk of death, exacerbation and disease severity among patients with COPD, but few studies... Background The body mass index, airflow obstruction, dyspnea, and exercise capacity (BODE) index was shown at predicting the risk of death, exacerbation and disease severity among patients with COPD, but few studies verified relationship between BODE index and health related quality of life (HRQoL) among Chinese COPD patients. The objective of this study was to evaluate the relationship between BODE index and HRQoL in cross-sectional and longitudinal association analyses. Methods A multi-center prospective cohort study was initially conducted in 491 stable COPD patients in Beijing, China. Health status (HRQoL) was assessed by St. George's Respiratory Questionnaire (SGRQ); the BODE index was calculated for each patient; dyspnea was assessed using the 5-grade Medical Research Council dyspnea scale. Other measurements included socio-demographic, body mass index (BMI), lung function test and 6-minute-walk test (6MWT). Patients were then followed monthly for 12 months. Results Only 450 patients completed the 1-year follow up and were enrolled in our present analyses. Mean age was (65.2 ±10.6)years,' men 309 (68.7%). The BODE index was categorized into 4 subgroups: 0-2, 3-4, 5-6 and 7-10. At baseline BODE index was gradually increased with baseline total SGRQ and SGRQ subscales (P trend 〈0.001). For individual components of BODE index, with the decrease of airflow limitation, and 6MWD, and with the increase of Medical Research Council (MRC) dyspnea grade, total SGRQ and SGRQ subscales were increased correspondingly, P trend 〈0.05, respectively. Similar association patterns were found between baseline BODE index and its individual components and mean SGRQ scores at the end of 1-year follow up. By multiple linear regression analyses, baseline BODE index was not only significantly associated with SGRQ score at baseline but also with SGRQ score at the end of 1-year follow up after adjustment for age, male, current smoking, 13s being 0.434 and 0.378, respectively. Conclusions BODE index is associated with SGRQ score cross-sectionally and longitudinally among stable COPD patients. BODE index might have potential to be used as a sensitive tool to assess the status of quality of life and to monitor disease progression among stable COPD patients. 展开更多
关键词 chronic obstructive pulmonary disease BODE index health-related quality of life St. George's RespiratoryQuestionnaire
原文传递
Effect of basic fibroblast growth factor on the proliferation, migration and phenotypic modulation of airway smooth muscle cells 被引量:9
4
作者 ZOU Hui nie xiu-hong +2 位作者 ZHANG Yi HU Mu ZHANG Yu Alex 《Chinese Medical Journal》 SCIE CAS CSCD 2008年第5期424-429,共6页
Background Proliferation, cell migration and phenotypic modulation of airway smooth muscle cells (ASMCs) are important features of airway remodelling in asthma. The precise cellular and molecular mechanisms that reg... Background Proliferation, cell migration and phenotypic modulation of airway smooth muscle cells (ASMCs) are important features of airway remodelling in asthma. The precise cellular and molecular mechanisms that regulate ASMCs proliferation, migration and phenotypic modulation in the lung remain unknown. Basic fibroblast growth factor (bFGF), a highly specific chemotactic and mitogenic factor for many cell types, appears to be involved in the development of airway remodelling. Our study assessed whether bFGF directly stimulates the proliferation, migration and phenotypic modulation of ASMCs. Methods Confluent and growth arrested human ASMCs were treated with human recombinant FGF. Proliferation was measured by BrdU incorporation and cell counting. Migration was examined using Boyden chamber apparatus. Expressions of smooth muscle (sm)-α-actin and sm-myosin heavy chain (MHC) isoform 1 were determined by RT-PCR and Westem blot analysis. Results It was found that hrbFGF (10 ng/ml), when added to ASMCs, induced a significant increase in BrdU uptake and cell number by ASMCs as compared to controls and a significant increase in ASMCs migration with respect to controls. The mRNA and protein expressions of sm-α-actin and sm-MHC in ASMCs that were stimulated with hrbFGF decreased with respect to controls. Conclusion It appears that bFGF can directly stimulate proliferation and migration of ASMCs, however, the expressions of cells' contractive phenotype decreased. 展开更多
关键词 ASTHMA basic fibroblast growth factor airway remodelling airway smooth muscle cells
原文传递
带GFP标签的SQSTM1真核表达载体的构建及功能验证
5
作者 朱祥 陈玉 +5 位作者 马路园 张德宇 刘娟 于世炎 聂秀红 徐小洁 《军事医学》 CAS 北大核心 2019年第6期411-414,共4页
目的构建带绿色荧光蛋白报告载体(pEGFP-C1)的死骨片1(SQSTM1/P62)真核表达载体,在获得pEGFPSQSTM1融合表达蛋白后,对其功能进行验证。方法以人乳腺文库为模板,通过聚合酶链反应(PCR)扩增人SQSTM1基因编码序列,插入到pEGFP-C1载体中,把... 目的构建带绿色荧光蛋白报告载体(pEGFP-C1)的死骨片1(SQSTM1/P62)真核表达载体,在获得pEGFPSQSTM1融合表达蛋白后,对其功能进行验证。方法以人乳腺文库为模板,通过聚合酶链反应(PCR)扩增人SQSTM1基因编码序列,插入到pEGFP-C1载体中,把测序正确的重组质粒转染人胚肾293T细胞,蛋白质印迹法(Western blotting)检测该融合蛋白表达情况;分别转染pEGFP-C1空载体、pEGFP-SQSTM1至乳腺癌细胞ZR75-1,荧光显微镜观察SQSTM1蛋白在细胞中的定位情况;荧光漂白后恢复实验(FRAP)验证乳腺癌细胞ZR75-1中SQSTM1小体荧光漂白后恢复情况。结果重组质粒pEGFP-SQSTM1的基因序列与目的序列完全一致,Western印迹检测蛋白表达成功;荧光显微镜观察SQSTM1的表达,结果显示,表达产物主要以点状小体形式定位于乳腺癌ZR75-1细胞的胞质中;FRAP实验验证乳腺癌细胞ZR75-1中SQSTM1小体激光漂白后绿色荧光可恢复。结论成功构建pEGFPSQSTM1真核表达载体,证实了SQSTM1蛋白在人乳腺癌细胞ZR75-1中表达,表达蛋白以点状小体形式定位于细胞质中,为进一步研究SQSTM1小体的功能提供基础。 展开更多
关键词 乳腺肿瘤 ZR75-1 pEGFP-SQSTM1 SQSTM1 SQSTM1小体 绿色荧光蛋白质类 聚合酶链反应
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部